Correlation between IL-7 and lymphocyte parameters in patients with cancer
| . | Baseline (n = 30) . | On therapy (n = 17) . | Off therapy (n = 12) . | ||||||
|---|---|---|---|---|---|---|---|---|---|
| r . | P . | Median . | r . | P . | Median . | r . | P . | Median . | |
| CD3 (cells/μL) | −0.14 | .44 | 1 080 | −0.24 | .34 | 272 | −0.32 | .29 | 812 |
| CD4 (cells/μL) | −0.25 | .18 | 639 | −0.65 | .009 | 76 | −0.70 | .02 | 200 |
| CD8 (cells/μL) | 0.04 | .82 | 348 | −0.14 | .57 | 108 | −0.06 | .84 | 396 |
| CD4+CD45RA+RO−(cells/μL) | −0.19 | .33 | 264 | −0.04 | .77 | 1.0 | −0.50 | .10 | 29 |
| CD4+CD45RO+RA−(cells/μL) | −0.23 | .23 | 269 | −0.60 | .02 | 70 | −0.76 | .02 | 127 |
| CD4:CD8 | −0.42 | .03 | 1.76 | −0.14 | .58 | 0.73 | −0.66 | .03 | 0.53 |
| B cells (cells/μL) | −0.21 | .40 | 174 | −0.46 | .05 | 4 | −0.26 | .39 | 200 |
| . | Baseline (n = 30) . | On therapy (n = 17) . | Off therapy (n = 12) . | ||||||
|---|---|---|---|---|---|---|---|---|---|
| r . | P . | Median . | r . | P . | Median . | r . | P . | Median . | |
| CD3 (cells/μL) | −0.14 | .44 | 1 080 | −0.24 | .34 | 272 | −0.32 | .29 | 812 |
| CD4 (cells/μL) | −0.25 | .18 | 639 | −0.65 | .009 | 76 | −0.70 | .02 | 200 |
| CD8 (cells/μL) | 0.04 | .82 | 348 | −0.14 | .57 | 108 | −0.06 | .84 | 396 |
| CD4+CD45RA+RO−(cells/μL) | −0.19 | .33 | 264 | −0.04 | .77 | 1.0 | −0.50 | .10 | 29 |
| CD4+CD45RO+RA−(cells/μL) | −0.23 | .23 | 269 | −0.60 | .02 | 70 | −0.76 | .02 | 127 |
| CD4:CD8 | −0.42 | .03 | 1.76 | −0.14 | .58 | 0.73 | −0.66 | .03 | 0.53 |
| B cells (cells/μL) | −0.21 | .40 | 174 | −0.46 | .05 | 4 | −0.26 | .39 | 200 |